The Role of Pharmacy Technicians in Hospital Formulary Maintenance

Pharmaceutical services. In: Accreditation manual for hospitals/88. Chicago: Joint Commission on Accreditation of healthcare Organizations, 1987: 126.

Dictionary of pharmacy. Columbia, SC: University of South Carolina Press, 1986.

Pierpaoli PG . How the formulary system works. US Pharm 1986; 11: H-1-8.

Stedman TL . Stedman's medical dictionary. Baltimore: Williams & Wilkins, 1978: 1327.

Tugwell AC Thurston DR Barrett CW . Design and preparation of a formulary—guide to the prescribing of medicines. J Clin Hosp Pharm 1984; 9: 311–9.

Hassan WE Jr . The hospital formulary. In: Hospital pharmacy. 5th ed. Philadelphia: Lea & Febiger, 1986: 124, 142–3.

Borreson RE . P & T committee role in advocating rational therapeutics. Hosp Form 1986; 21: 590–8.

Roberts MJ Summerfield MR . Formulary management to reduce cost: P & T committee strategies. Hosp Form 1986; 21: 481–92.

Pharmaceutical services. In: Accreditation manual for hospitals/88. Chicago: Joint Commission on Accreditation of Healthcare Organizations, 1987: 128, 182.

ASHP statement on the formulary system. In: Practice standards of the American Society of Hospital Pharmacists 1987–88. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 3–4.

ASHP technical assistance bulletin on hospital formularies. In: Practice standards of the American Society of Hospital Pharmacists 1987–88. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 130–2.

ASHP statement on the pharmacy and therapeutics committee. In: Practice standards of the American Society of Hospital Pharmacists 1987–88. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 2.

Butler CD Manchester R . The P & T committee: Descriptive survey of activities and time requirements. Hosp Form 1986; 21: 89–98.

Pierpaoli PG . How the formulary system works. US Pharm 1986; 22: H-1-8.

Most P & T committees influence hospital drug prescribing patterns. Hosp Form 1977; 12: 482.

Lucarotti R Shoup L Churchill WW . Strengthening the formulary system: Experience of 20 hospital pharmacists. In: Proceedings of a pharmacy conference. Secaucus, NJ: Advanced Therapeutics, 1986: 1–8.

Abramowitz PW . Controlling financial variables—changing prescribing patterns. Am J Hosp Pharm 1984; 41: 503–15.

Targeted ADR surveillance system looks at impact of adverse reactions. Drug Util Rev 1986; 2: 100–1.

Barker KN Mikeal RL Pearson RE Illig NA Morse ML . Medication errors in nursing homes and small hospitals. Am J Hosp Pharm 1982; 39: 987–91.

Abramowitz PW Nold EG Hatfield SM . Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm 1982; 39: 1176–80.

Guernsey BG Berina LF Lazarus MC . Cost containment through therapeutic substitution of aminoglycosides. Hosp Pharm 1985; 20: 82–93.

Hayman JN Sbravati EC . Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Am J Hosp Pharm 1985; 42: 1343–7.

Iafrate RP Smith PD . Documenting medication errors averted by pharmacists. Am J Hosp Pharm 1986; 43: 1672.

Jenkins J Brown T . Cost-effectiveness of standardized heparin and aminophylline solutions. NITA 1985; 8: 162–4.

Schwinghammer TL Romano MJ Wing EJ . Cost savings associated with use of gentamicin versus tobramycin. Am J Hosp Pharm 1985; 42: 1745–9.

Noel MW Paxinos J . Cephalosporins: Use review and cost analysis. Am J Hosp Pharm 1978; 35: 933–5.

Britton HL Schwinghammer TL Romano NJ . Cost containment through restriction of cephalosporins. Am J Hosp Pharm 1981; 38: 1897–9.

Quintiliani R Klimek JJ Nightingale CH . Restriction policies for therapy with combination antibiotics. J Infect Dis 1986; 153: 645–9.

Barriere SL Cone JE . Aminoglycoside use monitored by clinical pharmaceutical services. Am J Hosp Pharm 1979; 36; 1209–11.

Kimelblatt BJ Bradbury K Chodoff L Aggour T Mehl B . Cost-benefit analysis of an aminoglycoside monitoring service. Am J Hosp Pharm 1986; 43: 1205–9.

Greene SA Record KE Rapp RP Amerson AB Bell RM Piecoro JJ Jr . Pharmacy initiatives to reduce clindamycin use. Am J Hosp Pharm 1986; 43: 1210–3.

Bedford RF O'Brien TE . Comparison of bovine lung and porcine intestinal heparin for arterial thrombosis in man. Am J Hosp Pharm 1977; 34: 936–9.

Feldman MJ . Time and cost evaluation of premixed lidocaine as a component of a pharmacy-based I.V. admixture program. Am J IV Ther Clin Nutr 1984; 11: 21–31.

Hoover RC . Preliminary evaluation of a standardized protocol for continuous infusion heparin. Hosp Pharm 1981; 16: 464–75.

Jennings RH . Preventing problems with premixed theophylline intravenous infusions. Am J Hosp Pharm 1984; 41: 727–8.

Jurkiewicz GL Gambino DA Bloome GA . A standard aminophylline intravenous solution with flow rate label adapted to a manufacturer's standard solution. Hosp Pharm 1983; 18: 672–6.

Macleod CM Jameson J Bartley EA Matyas JG . Comparison of two methods of continuous intravenous infusion heparin therapy. Hosp Pharm 1985; 20: 649–54.

Oszko MA Fant WK . Cost-effectiveness analysis as a tool to compare two methods of preparing and administering intravenous heparin solutions. Hosp Pharm 1985; 20: 576–82.

Shoup LK . I.V. aminophylline/theophylline standardization: A case report. Deerfield, IL: Travenol Laboratories, Inc. November 1983: Reprint no. 413620.

Weyant H . Utilization of an intravenous drug guide. Focus Cri Care 1984; 11: 58–62.

Anandan JV . Reducing the number of formulary theophylline preparations. Am J Hosp Pharm 1981; 38: 511–3.

Saya FG Coleman LT Martinoff JT . Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm 1985; 42: 1965–9.

Zarowitz BJ Owen H Popovich JP Jr Pancorbo S . Evaluation of premixed gentamicin admixtures: Cost and clinical utility. Hosp Pharm 1987; 22: 257–60.

Ivey MF Baluch W Mueller W . Savings achieved through use of a less-concentrated amino acid solution. Am J Hosp Pharm 1979; 36: 57–9.

Raebel MA McDonald JB . Twenty-four-hour single-container system for parenteral nutrient admixtures. Am J Hosp Pharm 1985; 42: 1355–8.

McClendon RR . A comparative evaluation of methods used to compound parenteral nutrition solutions. Nutr Support Serv 1983; 3: 46–51.

Quart KA Poole RL MacKenzie N Stevenson DK Kerner JA Jr . The impact of computer-assisted parenteral nutrition for neonates. Nutr Support Serv 1985; 5: 30–5.

Petros WP Shank WA . A standardized parenteral nutrition solution: Prescribing, use, processing, and material cost implications. Hosp Pharm 1986; 21: 648–56.

Dalton MJ Schepers G Gee JP Alberts CC Eckhauser FE Kirking DM . Consultative total parenteral nutritional teams: The effect on the incidence of total parenteral nutrition-related complications. J Parenter Enter Nutr 1984; 8: 146–52.

Davis N . “Stats” and “nows.” Hosp Pharm 1986; 21: 157–9.

Morgan R Crane V . Enhancing antibiotic prescribing practices through a participative management approach. Paper presented at the 20th Annual American Society of Hospital Pharmacists Midyear Clinical Meeting. New Orleans, LA: December 12, 1985.

Daniels CS . The pharmacy and therapeutics committee/formulary system. In: Brown TR Smith MC . Handbook of institutional pharmacy practice. 2nd ed. Baltimore: Williams & Wilkins, 1986: 615.

New chemical entity ADRs accounted for one-fifth. FDC Rep February 9, 1987: T&G-5-6.

Chase K Meyer JD Kelly WN . Total formulary review—the easy way. Hosp Pharm 1984; 19: 159–62.

Slotfeldt ML . Formulary management. Hosp Form 1986; 21: 803–4.

Sudds TW Williams RR . The goals and functions of a P & T committee. Hosp Form 1985; 20: 1163–74.

Hogan GF . Liability associated with preparing injectable drugs in a hospital pharmacy. Am J Hosp Pharm 1986; 43: 1668–71.

Drug law. In: Survey of pharmacy law 1986–87. Park Ridge, IL: National Association of Boards of Pharmacy, 1986: 36.

Davis NM . The foremost problems associated with formulary management. Hosp Pharm 1983; 18: 131–42.

Suzuki NT . Cost benefit of pharmacist concurrent monitoring in cefazolin prescribing. Am J Hosp Pharm 1983; 40: 1187–91.

Suzuki NT . Pharmacist involvement in cefazolin prescribing. Am J Hosp Pharm 1986; 43: 1904–7.

Avorn J Soumerai SB . Improving drug-therapy decisions through educational outreach. N Engl J Med 1983; 308: 1457–63.

Manning PR Lee PV Clintworth WA Benson TA Oppenheimer PR Gilman NJ . Changing prescribing practices through individual continuing education. JAMA 1986; 256: 230–2.

Sohn CA Wolter HA McSweeney GW . Effectiveness of a cephalosporin education program—a pharmacy education program. Drug Intell Clin Pharm 1980; 14: 272–7.

Alexander MR Ambre JJ Liskow BI Trost DC . Therapeutic use of albumin. JAMA 1979; 241: 2527–9.

Elenbaas RM Payne VW Bauman JL . Influence of clinical pharmacist consultations on the use of drug blood level tests. Am J Hosp Pharm 1980; 37: 61–4.

Levin B Cohen SS Birmingham PH . Effect of pharmacist intervention on the use of serum drug assays. Am J Hosp Pharm 1981; 38: 845–51.

Slaughter RL Schneider PJ Visconti JA . Appropriateness of the use of serum digoxin and digitoxin assays. Am J Hosp Pharm 1978; 35: 1376–9.

Selective testing, reporting by lab can improve use of antimicrobials. Drug Util Rev 1986; 2: 72–3.

Mioduch HJ . Guidelines for serum drug level monitoring improve patient therapy and reduce costs. Drug Util Rev 1986; 2: 73–5.

Miller M . Scheduling piggybacks. Hosp Pharm 1986; 21: 170–1.

Habeger HE . Drug order audit. Hosp Pharm 1986; 21: 157–8.

Green JA Chawla AK Fong PA . Evaluating a restrictive formulary system by assessing nonformulary-drug requests. Am J Hosp Pharm 1985; 42: 1537–41.

Jeffrey LP Gallina JN . How a nonformulary medication request form is cost-effective. Pharm Times 1984; 50: 50–1.

Packer LA Mahoney CD Rich DS Jeffrey LP . Effect of pharmacists' clinical interventions on nonformulary drug use. Am J Hosp Pharm 1986; 43: 1461–6.

Seip K . A restricted antibiotic order form. Hosp Pharm 1985; 20: 775–6.

Haas CE Paladino JA Dibona JR . Effect of a preprinted chart note on appropriate cefazolin prescribing. Am J Hosp Pharm 1986; 43: 1754–6.

Committee opens communications between pharmacy and nursing. Drug Util Rev 1986; 2: 106–7.

ASHP guidelines for obtaining authorization for pharmacists' notations in the patient medical record. In: Practice standards of the American Society of Hospital Pharmacists 1987–88. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 32.

Lab sends physicians a message to influence use of antibiotics. Drug Util Rev 1986; 2: 59–60.

McCue JD . P & T committee guidelines for antibiotic cost comparisons. Hosp Form 1986; 21: 703–6.

Cornelis WA Milan B Mankowski RE . Additional ways to inform physicians of therapeutic alternatives. Am J Hosp Pharm 1985; 42: 1936.

Harteker LR . Producing a general-interest pharmacy newsletter for nurses and physicians. Am J Hosp Pharm 1986; 43: 1408–11.

Stevenson JG . Gaining physician support of a closed formulary. Hosp Form 1985; 20: 1105.

McKeegan GM . Survey offers physicians a voice in formulary decisions. Drug Util Rev 1985; 1: 113–6.

Taylor T . Prescribing survey one step toward establishing formulary. Drug Util Rev 1985; 1: 141–3.

Pawlak R . Ways to overcome opposition to P & T committee decisions. Hosp Form 1986; 21: 507–8.

ASHP statement on supportive personnel in hospital pharmacy. In: Practice standards of the American Society of Hospital Pharmacists 1987–88. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 7.

Bruner WR Douglas AS . Involving pharmacy technicians on hospital committees. Am J Hosp Pharm 1986; 43: 304–12.

McCarthy ID . Transferring nonjudgmental tasks from pharmacists to technicians. Am J Hosp Pharm 1986; 43: 1168.